Deceptive imprinting: Insights into mechanisms of immune evasion and vaccine development

Advances in Veterinary Medicine

Volumn 41, Issue C, 1999, Pages 115-134

  Nara, Peter L ^a  

^a Biological Mimetics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL; B LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; REVIEW; T LYMPHOCYTE; VACCINATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; B-LYMPHOCYTES; EPITOPES; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; T-LYMPHOCYTES; VACCINATION; VACCINES;

EID: 0032615727     PISSN: 1093975X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-3519(99)80012-3     Document Type: Chapter

References (69)

1. Albright J.F., Omer T.F., and Deitchman J.W. Antigenic competition: Antigens compete for a cell occurring with limited frequency. Science 167 (1970) 196
2. Amadori A., and Chieco-Bianchi L. B cell activation and HIV infection: Protective or potentially detrimental response?. Int. Rev. Immunol. 9 (1992) 15-24
3. Angelova L.A., and Shvartsman Y.S. Original antigenic sin to influenza in rats. Immunology 46 (1982) 183-188
4. Arthur L.A., Bess Jr. J.W., Waters D.J., Pyle S.W., Kelliher J.C., Nara P.L., Krohn K., Robey W.G., Langlois A.J., Gallo R.C., and Fischinger P.J. Challenge of chimpanze (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein, gp120. J. Virol. 63 (1989) 5046-5053
5. Back N.K.T., Smit L., Schutten M., Nara P.L., Tersmette M., and Goudsmit J. Mutations in human immundeficiency virus type 1 gp41 after sensivity to neutralization by gp120 antibodies. J. Virol. 67 (1993) 6897-6902
6. Benjamin D.C., Berzofksky J.A., East I.J., Gurd F.N., Hannum C., Leach S.J., Margoliash E., Michael J.G., Miller A., Prager E.M., Reichlin M., Sercarz E.E., Smith-Gill S.J., Todd P.E., and Wilson A.C. The antigenic structure of proteins: A reprasial. Annu. Rev. Immunol. 2 (1984) 67-101
7. Berberian L. Immunoglobulin VH3 gene products: natural ligands for HIV gp120. Science 261 (1993) 1588-1591
8. Briault S., Courtois-Capella M., Duarter F., Aucouturier P., and Preud'Homme J.L. Isotypy of serum monoclonal immunoglobulins in human immundeficiency virus-infected adults. Clin. Exp. Immunol. 74 2 (1988) 182-184
9. Briles D.E., and Davie J.M. Clonal nature of the immune response. II. The effect of immunization on clonal commitment. J. Exp. Med. 152 (1980) 151-160
10. Coffman R.L., Lebman D.A., and Shrader B. Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J. Exp. Med. 170 3 (1989) 1039-1044
11. Colle J.-H., LeMoal M.A., and Truffa-Bachi P. Immunological memory. Crit. Rev. Immunol. 10 (1990) 270-288
12. Davis D., Chaudhri B., Stephens D.M., Carne C.A., Willers C., and Lachmann P.J. The immunodominance of epitopes within the transmembrane protein (gp41) of human immunodeficiency virus type 1 may be determined by the hosts previous exposure to similar epitopes on unrelated antigens. J. Gen. Virol. 71 (1990) 1975-1983
13. Ezekowitz R.A.B., Kuhlman M., Groopman J.E., and Byrn R.A. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J. Exp. Med. 169 (1989) 185-196
14. In: Fenner F., McAuslan B.R., Mims C.A., Sambrook J., and White D.O. (Eds). The Biology of Animal Viruses. 2nd ed. (1974), Academic Press, London 417-418
15. Garrity R., Rimmelzwaan G., Minassin A., Tsai W.-P., Lin G., de Jong J.-J., Goudsmit J., and Nara P.L. Refocusing neutralizing antibody response by targeted dampening of an immunodominant epitope. J. Immunol. 159 (1997) 279-289
16. Gonzalez-Scarano F., Waxham M.N., Ross A.M., and Hoxie J.A. Sequence similarities between human immunodeficiency virus gp41 and paramyxovirus fusion proteins. AIDS Res. Hum. Retroviruses 3 (1987) 242-252
17. Hansen J.-E.S., Clausen H., Nielsen C., Teglbjaerg L.S., Hansen L.L., Nielsen C.M., Dabelsteen E., Mathiesen L., Hakomori S.-I., and Nielsen J.O. Inhibition of human immunodeficiency virus (HIV0 infection in vitro by anticarbohydrate monoclonal antibodies Peripheral blycosylation of HIV envelope blycoprotein gp120 may be a target for virus neutralization. J. Virol. 64 (1990) 2833-2840
18. Harboe M. Recognition of two distinct groups of human IgM and IgA based on different binding to staphylococci. Scand. J. Immunol. 3 4 (1974) 471-482
19. Humbert J., Motta I., and Truffa-Bachi P. TNP-LPS induces an IgG anti-TNP immune response in mice. Cell. Immunol. 47 (1979) 211
20. Inganas M. Comparison of mechanisms of interaction between protein A from Staphylococcus aureus and human monoclonal IgG, IgA and IgM in relation to the classical FC gamma and the alternative F(ab')2 epsilon protein A interactions. Scand. J. Immunol. 13 4 (1981) 343-352
21. Kakiuchi T., Watanabe M., Hozumi N., and Nariuchi H. Differential sensitivity of specific and nonspecific antigen-presentation by B cells to a protein synthesis inhibitor. J. Immunol. 145 6 (1990) 1653-1658
22. Kalams S.A., Johnson R.P., Trocha A.K., Dynan M.J., Ngo H.S., D'Aquila R.T., Kurnick J.T., and Walker B.D. Longitudinal analysis of the T cell receptor (TCR) gene usage by humnan immunodeficiency virus 1 envelope-speecific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 179 (1994) 1261-1271
23. Kalyanaraman V.S., Pal R., Gallo R.C., and Sarngadharan G. A unique human immunodeficiency virus culture secreting soluble gp160. AIDS Res. Hum. Retroviruses 4 (1988) 319-329
24. Kalyanaraman V.S., Rodriguez V., Veronese F., Rahman R., Lusso P., DeVico A.L., Copeland T., Oroszlan S., Gallo R.C., and Sarngadharan M.G. Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 6 (1990) 371-380
25. Kittlesen D.J., Brown L.R., Braciale V.L., Sambrook J.P., Gething M.-J., and Braciale T.J. Presentation of newly synthesized glycoproteins to CD4+ T lymphocytes. An analysis using influenza hemagglutinin transport mutants. J. Exp. Med. 177 (1993) 1021-1030
26. Kohler H., Goudsmit J., and Nara P.L. Clonal antibody dominance in HIV-1 infection Cause for a limited and failing immune response to HIV-1 infection and vaccination. J. Acquired Immune Defic. Syndr. 5 (1992) 1158-1168
27. Kohler H., Muller S., and Nara P. Deceptive imprinting in the immune response against HIV-1. Immunol. Today 13 (1994) 475-478
28. Kunkl A., and Klaus G.G.B. The generation of memory cells. V. Preferential priming of IgG1 B memory cells by immunization with antigen IgG2 antibody complexes. Immunology 44 (1981) 163
29. Kuruvilla A.P., Shah R., Hochwald G.M., Liggitt H.D., Palladino M.A., and Thorbecke G.J. Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc. Natl. Acad. Sci. USA 88 7 (1991) 2918-2921
30. Langone J.J. Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumonococci. Adv. Immunol. 32 (1982) 157-252
31. Lin Y.A., and Stavnezer J. Regulation of transcription of the germ-line Ig alpha constant region by an ATF element and by novel transforming growth factor-beta 1 responsive elements. J. Immunol. 149 (1992) 2914
32. Lorenz R.G., Blum J.S., and Allen P.M. Constitutive competition by self proteins for antigen presentation can be overcome by receptor-enhanced uptake. J. Immunol. 144 (1990) 1600-1608
33. Martinez-Maza O., Crabb E., Mitsuyasu R.T., Fahey J.L., and Giorgi J.V. Infection with human immundeficiency virus (HIV) is associated with an increase in B lymphocyte activation and immaturity. J. Immunol. 138 (1987) 3720-3724
34. Mathiesen T., Sonnerborg A., von Sydow M., Gaines H., and Wahren B. IgG subclass reactivity against human immunodeficiency virus (HIV) and cytomegalo-virus in cerebrospinal fluid and serum from HIV-infected patients. J. Med. Virol. 25 (1988) 17-26
35. Mathiesen T., Chiodl F., Broliden P.-A., Houghten A.J., Utter R.A., Wahren B., and Norrby E. Analysis of a subclass-restricted HIV-1 gp41 epitope by omission peptides. Immunology 67 (1989) 1-7
36. Mitchell G.F. Co-evolution of parasites and adaptive immune responses. Immunol. Today 12 3 (1991) A2-A5
37. Moller G., and Sjöberg O. Effect of antigenic competition on antigen-sensitive cells and on adoptively transferre immunocompetent cells. Cell. Immunol. 1 1 (1970) 110-121
38. Moore J.P., Cao Y., Ho D.D., and Koup R.A. Development of the anti-gp120 antibod response during seroconversion to human immunodeficiency virus type 1. J. Virol. 68 (1994) 5142-5155
39. Mosier D.E., Johnson B.M., Paul W.E., and McMaster P.R.B. Cellular requirements for the primary in vitro antibody response to DNP-Ficoll. J. Exp. Med. 139 (1974) 1354
40. Muller S., Nara P., D'Amelio R., Biselli R., Gold D., Wang H., and Silverman G.J. Clonal patterns in the human immune response to HIV-1 infection. Int. Rev. Immunol. 9 (1992) 1-13
41. Nair B.C., Ford G., Kalyanaraman V.S., Zafari M., Fang C., and Sarngadharan M.G. Enzyme immunoassay using negative envelope glycoprotein (gp160) for detection of human immunodeficiency virus type 1 antibodies. J. Clin. Microbiol. 32 6 (1994) 1449-1456
42. Chapter 12. Nara P.L. Humoral immunity to HIV-1: Lethal force or trojan horse?. In: Gupta S. (Ed). Immunology of HIV Infection (1996), Plenum, New York
43. Nara P.L., and Goudsmit J. Clonal dominance of the neutralizing response to the HIV-1 V3 epitope: Evidence for "Originak Antigenic Sin" during vaccination and infection in animals, including humans. In: Lerner R.A., Ginsberg H., Chanock R.M., and Brown F. (Eds). Vaccines 91 (1991), Cold Spring Harbor Lab. Press, Cold Spring Harbor, NY 51-58
44. Nara P.L., Smit L., Dunlop N., Natch W., Merges M., Waters D., Kelliher J., Gallo R.C., Fischinger P.J., and Goudsmit J. Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees. J. Virol. 64 (1990) 3779-3791
45. Ng V.L., Hwang K.M., Reyes G.R., Kaplan L.D., Khayam-Bashi H., Hadely W.K., and McGrath M. High titer anti-HIV antibody reactivity associated with a paraprotein spike in a homosexual male with AIDS related complex. Blood 71 (1988) 1397-1401
46. Pang S., Sclesinger Y., Darr E.S., Moudgil T., Ho D.D., and Chen I.S. Rapid generation of sequence variation during primary infection. AIDS 6 (1992) 453-460
47. Pantalero G., Demarest J.F., Soudeyns H., Grazioso C., Denis F., Adelsberger J.W., Borrow P., Saag M.S., Shaw G.M., Sekaly R.P., and Fauci A.S. Major expansion of CD8+ T cells with a predominant VB usuage during the primary immune response to HIV. Nature 370 (1994) 463-467
48. Race E.M., Ramsey K.M., Lucia H.L., and Cloyd M.W. Human immunodeficiency virus elicits antibody not detected by standard tests: Implications for diagnostics and viral immunology. Virology 184 (1991) 716-722
49. Radovick J., and Talmadge D.W. Antigenic competition: Cellular or humoral. Science 158 (1967) 512
50. Rowley D.A., and Stach R.M. A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigens. J. Exp. Med. 178 3 (1993) 835-840
51. Rude E., Wrede J., and Gundelach M.L. Production of IgG antibodies and enhanced response of nude mice to DNP-AE-Dextran. J. Immunol. 116 (1976) 527
52. Sayre K.R., Dodd R.Y., Tegtmeier G., Layug L., Alexander S.S., and Busch M.P. False-positive human immunodeficiency virus type 1 Western blot tests in noninfected blood donors. Transfusion 36 (1996) 45-52
53. Schechter I. Antigenic competition between polypeptidyl determinants in normal and tolerant rabbits. J. Exp. Med. 127 (1968) 237-250
54. Schnittman S., Lane H., Higgins S., and Folks T. Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus. Science 233 (1986) 1084-1088
55. Sharon R., McMaster P.R.B., Kask A.M., Owens J.D., and Paul W.E. DNP-Lys-Ficol: A T-independent antigen which elicits both IgM and IgG anti-DNP antibody-secreting cells. J. Immunol. 114 (1975) 1585
56. Silverman G.J. Superantigens and the spectrum of unconventional B-cell antigens. Immunologist 2 2 (1994) 51-57
57. Silverman G.J., and Kohler H. Clonal restriction in human antibody responses to unfections. Int Rev. Immunol. 9 1 (1992) 1-57
58. Sonoda E., Matsumoto R., Hitoshi Y., Ishii T., Sugimoto M., Araki S., Tominaga A., Yamaguchi N., and Takatsu K. Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production. J. Exp. Med. 170 4 (1989) 1415-1420
59. Stach R.M., and Rowley D.A. A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor β and suppresses cytolytic T cell responses to unrelated alloantigens. J. Exp. Med. 178 (1993) 841-852
60. Sundqvist V.-A., Linde A., Kurtu R., Werner A., Helm E.B., Popovic M., Gallo R.C., and Wahren B. Restricted IgG subclass responses to HTLV III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome. J. Infect. Dis. 153 (1986) 970-973
61. Tomiyama T., Lake D., Masuho Y., and Hersh E.M. Recognition of human immunodeficiency virus glycoproteins by natural anti-carbohydrate antibodies in human serum. Biochem. Biophys. Res. Commun. 177 (1991) 279-285
62. Van Cott T.C., Veit S.C.D., Kalyanaraman V., Earl P., and Birx D.L. Characterization of a soluble, oligomeric HIV-1 gp160 protein as a potential immunogen. J. Immunol. Methods 183 (1995) 103-117
63. Veenhoff E., and Seijen H.G. Plasma cells and their precursors I. Preexistent antibody-forming cell precursors dominate the anti-sheep red blood cell and antihuman gamma globulin IgG antibody response. Immunobiology 162 (1982) 165-174
64. Vijayakrishnan L., Kumar V., Agrewala J.N., Mishra G.C., and Rao K.V.S. Antigen-specific early primary humoral responses modulate immunodominance of B cell epitopes. J. Immunol. 153 (1994) 1613
65. Waterson R.H. Antigenic competition: A paradox. Science 170 (1970) 1108
66. Wolfs T.F., Zwart G., Bahher M., and Goudsmit J. Hiv-1 genomic RNA diversification following sexual and parental transmission. Virology 189 (1992) 103-110
67. Zhang L.Q., MacKenzie P., Cleland A., Holmes E.C., Leigh-Brown A.J., and Simmonds P. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J. Virol. 67 (1993) 3345-3356
68. Zhu T., Mo H., Wang N., Nam D.S., Cho Y., Kuup R.A., and Ho D.D. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 261 (1993) 1179-1181
69. Zubler R.H., Perrin L.H., Doucet A., Zhang X., Huang Y.-P., and Miescher P.A. Frequencies of HIV-reactive B cells in seropositive and seronegative individuals. Clin. Exp. Immunol. 87 (1991) 31-36